Given there are serious limitations to pharmaceutical cannabinoid medications, it’s clear that the problem lies in the insurance system that has yet to evolve alongside patients’ needs and medical science. There is a clear disconnect when insurance companies can cover synthetic cannabinoid drugs but can’t acknowledge the medicinal value of whole cannabis compounds. Then again, the issue circles back to the federal government.
Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…
A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…
Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…
Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…
On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…
Is cannabis a miracle cure or a gateway to ruin? We break down the latest…